[
    "{\"step_by_step_thinking\": \"Based on the provided documents, there is evidence suggesting that there is a favorable subset of patients with prostate cancer who develop oligometastases. Several studies have shown improved clinical outcomes and survival in patients with oligometastatic prostate cancer who receive metastasis-directed therapy or local therapy. These treatments have been associated with prolonged survival, delayed initiation of systemic therapy, and improved disease control. Additionally, there is ongoing research and interest in the concept of oligometastasis in prostate cancer, with efforts to refine the definition of oligometastatic disease and identify predictive and prognostic biomarkers. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]